Real-life Safety Profile of ZRC3197 (Adalimumab Biosimilar) in Indian Patients with Common Rheumatic Diseases. [electronic resource]
- The Journal of the Association of Physicians of India May 2017
- 30-32 p. digital
Publication Type: Journal Article
0004-5772
Adalimumab--adverse effects Antirheumatic Agents--adverse effects Biosimilar Pharmaceuticals--adverse effects Female Humans India Male Rheumatic Diseases--drug therapy